ATE239485T1 - Ophthalmische pharmazeutische zubereitung die n- acetylcystein und polyvinylalkohol enthält - Google Patents

Ophthalmische pharmazeutische zubereitung die n- acetylcystein und polyvinylalkohol enthält

Info

Publication number
ATE239485T1
ATE239485T1 AT93100278T AT93100278T ATE239485T1 AT E239485 T1 ATE239485 T1 AT E239485T1 AT 93100278 T AT93100278 T AT 93100278T AT 93100278 T AT93100278 T AT 93100278T AT E239485 T1 ATE239485 T1 AT E239485T1
Authority
AT
Austria
Prior art keywords
acetylcysteine
polyvinyl alcohol
pharmaceutical preparation
ophthalmic pharmaceutical
preparation containing
Prior art date
Application number
AT93100278T
Other languages
English (en)
Inventor
Federico Stroppolo
Daniele Bonadeo
Francesco Tocchini
Annibale Gazzaniga
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Application granted granted Critical
Publication of ATE239485T1 publication Critical patent/ATE239485T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT93100278T 1992-01-16 1993-01-11 Ophthalmische pharmazeutische zubereitung die n- acetylcystein und polyvinylalkohol enthält ATE239485T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI920074A IT1258781B (it) 1992-01-16 1992-01-16 Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol

Publications (1)

Publication Number Publication Date
ATE239485T1 true ATE239485T1 (de) 2003-05-15

Family

ID=11361572

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93100278T ATE239485T1 (de) 1992-01-16 1993-01-11 Ophthalmische pharmazeutische zubereitung die n- acetylcystein und polyvinylalkohol enthält

Country Status (9)

Country Link
US (2) US5510101A (de)
EP (1) EP0551848B1 (de)
JP (1) JP3443128B2 (de)
AT (1) ATE239485T1 (de)
AU (1) AU653091B2 (de)
CA (1) CA2087420C (de)
DE (1) DE69332939T2 (de)
ES (1) ES2197146T3 (de)
IT (1) IT1258781B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2350715A1 (en) * 1999-08-09 2001-04-12 Webb-Waring Institute For Biomedical Research A method for the treatment of ocular oxidative stress
US7022315B2 (en) * 2000-04-26 2006-04-04 Oregon Health & Science University Administration of a thiol-based chemoprotectant compound
EP1609468A3 (de) * 2000-11-22 2006-01-25 Rxkinetix, Inc. Eine Zusammensetzung auf der Basis eines Schwefel enthaltenden Antioxidans wie dessen Verwendung zur Herstellung eines Medikaments für die Behandlung von Mucositis
FR2819186A1 (fr) * 2001-01-10 2002-07-12 L M D Cystine-voie orale-syndrome de l'oeil sec
ITRM20010438A1 (it) * 2001-07-23 2003-01-23 Farmigea Spa Preparato oftalmico a base di n-acetilcisteina per il trattamento della sindrome dell'occhio secco.
GB0123115D0 (en) * 2001-09-26 2001-11-14 Pharma Sol Int Ltd Saline solutions for clinical use
US20050118261A1 (en) * 2003-06-12 2005-06-02 Oien Hal J. Compositions and methods of administering doxepin to mucosal tissue
US20070077303A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for providing oxidatively stable ophthalmic compositions
CA2635603C (en) * 2005-11-30 2016-01-19 Endo Pharmaceuticals Inc. Treatment of xerostomia
SG10202003901UA (en) 2005-12-13 2020-05-28 Incyte Holdings Corp Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
KR20150036210A (ko) 2007-06-13 2015-04-07 인사이트 코포레이션 야누스 키나제 억제제（Ｒ）―３―（４―（７Ｈ―피롤로［２，３－ｄ］피리미딘―4―일）―1Ｈ―피라졸―1―일）―３―사이클로펜틸프로판니트릴의 염
CL2009001884A1 (es) * 2008-10-02 2010-05-14 Incyte Holdings Corp Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
AR076794A1 (es) 2009-05-22 2011-07-06 Incyte Corp Derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo [2,3-d]pirimidinas y pirrol-3-il-pirrolo [2,3-d ]pirimidinas como inhibidores de la quinasa janus y composiciones farmaceuticas que los contienen
SI2432472T1 (sl) * 2009-05-22 2019-11-29 Incyte Holdings Corp 3-(4-(7H-pirolo(2,3-d)pirimidin-4-il)-1H-pirazol-1-il)oktan- ali heptan-nitril kot inhibitorji JAK
TW201113285A (en) * 2009-09-01 2011-04-16 Incyte Corp Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
EP3354652B1 (de) 2010-03-10 2020-05-06 Incyte Holdings Corporation Piperidin-4-yl azetidin-derivate als jak1-inhibitoren
PE20130216A1 (es) 2010-05-21 2013-02-27 Incyte Corp Formulacion topica para un inhibidor de jak
PE20140146A1 (es) 2010-11-19 2014-02-06 Incyte Corp Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak
US9034884B2 (en) 2010-11-19 2015-05-19 Incyte Corporation Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors
CN103797010B (zh) 2011-06-20 2016-02-24 因塞特控股公司 作为jak抑制剂的氮杂环丁烷基苯基、吡啶基或吡嗪基甲酰胺衍生物
TW201313721A (zh) 2011-08-18 2013-04-01 Incyte Corp 作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
UA111854C2 (uk) 2011-09-07 2016-06-24 Інсайт Холдінгс Корпорейшн Способи і проміжні сполуки для отримання інгібіторів jak
TW201406761A (zh) 2012-05-18 2014-02-16 Incyte Corp 做爲ｊａｋ抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物
PH12020551186B1 (en) 2012-11-15 2024-03-20 Incyte Holdings Corp Sustained-release dosage forms of ruxolitinib
RS62867B1 (sr) 2013-03-06 2022-02-28 Incyte Holdings Corp Postupci i intermedijeri za dobijanje inhibitora jak
SMT202000315T1 (it) 2013-08-07 2020-07-08 Incyte Corp Forme di dosaggio a rilascio prolungato per un inibitore di jak1
EP3139903B1 (de) 2014-05-07 2019-07-03 Croma-Pharma Gesellschaft m.b.H. Wässrige opthalmische lösung und verfahren zur behandlung von trockenem augensyndrom
US9498467B2 (en) 2014-05-30 2016-11-22 Incyte Corporation Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
KR20180066240A (ko) 2015-10-30 2018-06-18 크로마-파르마 게젤샤프트 엠.베.하. 무균 수성 안과용 액제의 치료적 용도
RU2741912C2 (ru) 2015-10-30 2021-01-29 Крома-Фарма Гезелльшафт М.Б.Х. Применение в терапии стерильного водного офтальмологического раствора
EP3600272A4 (de) * 2017-03-29 2021-01-13 Azura Ophthalmics Ltd. Mittel zur erhöhung der lipidsekretion der meibomdrüse
WO2018202783A1 (en) 2017-05-03 2018-11-08 Croma-Pharma Gmbh Sterile aqueous ophthalmic solution containing n-(n-acetylcysteinyl)-chitosan for treating non-infectious corneal disorders
WO2019113487A1 (en) 2017-12-08 2019-06-13 Incyte Corporation Low dose combination therapy for treatment of myeloproliferative neoplasms
SG11202007164UA (en) 2018-01-30 2020-08-28 Incyte Corp Processes for preparing (1 -(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one)
SMT202400306T1 (it) 2018-03-30 2024-09-16 Incyte Corp Trattamento dell'idrosadenite suppurativa utilizzando inibitori di jak.
US20220409526A1 (en) * 2019-11-08 2022-12-29 Retina Foundation Of The Southwest Compounds and implants for treating ocular disorders
US11833155B2 (en) 2020-06-03 2023-12-05 Incyte Corporation Combination therapy for treatment of myeloproliferative neoplasms

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4120949A (en) * 1977-10-05 1978-10-17 Cooper Laboratories, Inc. Ophthalmic solution
US4131651A (en) * 1977-10-25 1978-12-26 Barnes-Hind Pharmaceuticals, Inc. Treatment of dry eye
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
BE901885A (fr) * 1985-03-06 1985-07-01 Bruschettini Srl Composition pharmaceutique sous forme de lotion ophtalmique et son procede de preparation.
US4883658A (en) * 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
IT1249047B (it) * 1991-02-21 1995-02-11 Zambon Spa Composizione farmaceutica per il trattamento della cataratta
NZ242358A (en) * 1991-05-10 1994-03-25 Allergan Inc Use of thiol compounds to inhibit deposits on a contact lens

Also Published As

Publication number Publication date
AU653091B2 (en) 1994-09-15
ITMI920074A0 (it) 1992-01-16
ES2197146T3 (es) 2004-01-01
DE69332939T2 (de) 2004-04-01
CA2087420C (en) 2004-04-20
CA2087420A1 (en) 1993-07-17
US5510101A (en) 1996-04-23
AU3113693A (en) 1993-07-22
ITMI920074A1 (it) 1993-07-16
JP3443128B2 (ja) 2003-09-02
EP0551848B1 (de) 2003-05-07
JPH069383A (ja) 1994-01-18
US5488069A (en) 1996-01-30
EP0551848A1 (de) 1993-07-21
DE69332939D1 (de) 2003-06-12
IT1258781B (it) 1996-02-29

Similar Documents

Publication Publication Date Title
ATE239485T1 (de) Ophthalmische pharmazeutische zubereitung die n- acetylcystein und polyvinylalkohol enthält
RU94040170A (ru) Изохинолины
AU659444B2 (en) Intermediates for the manufacture of 6-fluoro-1, 4-dihydro-4-oxoquinoline carboxylic acids
DK153687A (da) Laegemiddel-adsorbater og deres fremstilling
OA09123A (fr) Composition pharmaceutique pour la prévention des maladies sexuellement transmissibles.
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
ES2057124T3 (es) Producto terapeutico para el tratamiento de estados peri- o post-menopausicos.
NO890259L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
DE69326539D1 (de) Zytotoxische arzneimittel therapie
RU93045145A (ru) Замещенные производные циклогексана и их применение для лечения заболеваний, содержащее их лекарственное средство
EP0235589A3 (en) Use of quinolone and naphthyridine antibiotics for the manufacture of ophthalmic medicaments
IT1231107B (it) Procedimento e dispositivo per la fabbricazione di lattine mediante stiramento.
FI945000A0 (fi) Menetelmä (S)-amino-1-substituoitujen pyrrolidiinien valmistamiseksi
NO175307C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive 3,3'-ditiobis(propionsyrer)
NZ250300A (en) Asymmetric pyrrolidine derivatives
AU3709289A (en) Strontium salt
IT9020968A0 (it) Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche
ATE172114T1 (de) Pharmazeutische zusammensetzung, die carbachol und andere cholinerge substanzen enthält
NO881884L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
ITMI922296A0 (it) Procedimento per la preparazione di antibiotici beta-lattamici sterili
IL89401A0 (en) Medicaments containing 1,4-dihydropyridine derivatives for the treatment of alcohol addiction
BR9302809A (pt) Composto,processo para sua preparacao,processo de purificacao dos compostos,medicmanto,emprego e processo para a preparacao de um agente anti-tumoral
AU7379587A (en) Pharmaceutical formulation for the treatment of bacterial infections
AU6600190A (en) Therapeutic compositions; methods for treatment of hiv infections
AU2776389A (en) Beta-lactam antibiotics, processes for their preparation and their use as and in medicaments

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0551848

Country of ref document: EP

REN Ceased due to non-payment of the annual fee